China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
China’s medical products regulator has given conditional approval to Pfizer’s Covid-19 oral antiviral. The Chinese nod makes Paxlovid the first approved coronavirus oral pill in the country.
Pfizer may have beaten local competition to get the first approval for an oral Covid-19 antiviral in China, but Chinese companies are working hard to get a slice of the market.
It's free! Log in now to read
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03